{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T06:36:49Z","timestamp":1776667009647,"version":"3.51.2"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"French National Agency for Medicines and Health Products Safety","award":["EPI-PHARE call for proposals no. 2022S058\/EC 2022-05"],"award-info":[{"award-number":["EPI-PHARE call for proposals no. 2022S058\/EC 2022-05"]}]},{"name":"French Biomedicine Agency"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-026-07113-6","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T10:33:17Z","timestamp":1773225197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug prescription before and after dialysis initiation in older patients: a nationwide study"],"prefix":"10.1186","volume":"26","author":[{"given":"L\u00e9a","family":"Faure","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pernelle","family":"Noize","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Couchoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Hucteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Berdougo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florent","family":"Guerville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Harambat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Combe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Levassort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Moranne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aghil\u00e8s","family":"Hamroun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Baptiste","family":"Beuscart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Leffondr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Prezelin-Reydit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"REIN registry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"7113_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00228-013-1639-9","volume":"70","author":"RA Payne","year":"2014","unstructured":"Payne RA, Avery AJ, Duerden M, Saunders CL, Simpson CR, Abel GA. Prevalence of polypharmacy in a Scottish primary care population. Eur J Clin Pharmacol. 2014;70:575\u201381. https:\/\/doi.org\/10.1007\/s00228-013-1639-9.","journal-title":"Eur J Clin Pharmacol"},{"key":"7113_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6904-10-16","volume":"10","author":"B Hovstadius","year":"2010","unstructured":"Hovstadius B, Hovstadius K, Astrand B, Petersson G. Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol. 2010;10:16. https:\/\/doi.org\/10.1186\/1472-6904-10-16.","journal-title":"BMC Clin Pharmacol"},{"key":"7113_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12877-020-1485-4","volume":"20","author":"C Roux-Marson","year":"2020","unstructured":"Roux-Marson C, Baranski JB, Fafin C, Exterman G, Vigneau C, Couchoud C, et al. Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease. BMC Geriatr. 2020;20:87. https:\/\/doi.org\/10.1186\/s12877-020-1485-4.","journal-title":"BMC Geriatr"},{"key":"7113_CR4","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s40266-018-0563-1","volume":"35","author":"A Secora","year":"2018","unstructured":"Secora A, Alexander GC, Ballew SH, Coresh J, Grams ME. Kidney function, polypharmacy, and potentially inappropriate medication use in a community-based cohort of older adults. Drugs Aging. 2018;35:735\u201350. https:\/\/doi.org\/10.1007\/s40266-018-0563-1.","journal-title":"Drugs Aging"},{"key":"7113_CR5","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1111\/bcp.13738","volume":"84","author":"SM Laville","year":"2018","unstructured":"Laville SM, Metzger M, Stengel B, Jacquelinet C, Combe C, Fouque D, et al. Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort. Br J Clin Pharmacol. 2018;84:2811\u201323. https:\/\/doi.org\/10.1111\/bcp.13738.","journal-title":"Br J Clin Pharmacol"},{"key":"7113_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2147\/CLEP.S153458","volume":"10","author":"L Morin","year":"2018","unstructured":"Morin L, Johnell K, Laroche M-L, Fastbom J, Wastesson JW. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol. 2018;10:289\u201398. https:\/\/doi.org\/10.2147\/CLEP.S153458.","journal-title":"Clin Epidemiol"},{"key":"7113_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5414\/cpp46072","volume":"46","author":"P Gallagher","year":"2008","unstructured":"Gallagher P, Ryan C, Byrne S, Kennedy J, O\u2019Mahony D. Stopp (screening tool of older person\u2019s prescriptions) and start (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46:72\u201383. https:\/\/doi.org\/10.5414\/cpp46072.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"7113_CR8","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00228-021-03145-6","volume":"77","author":"B Roux","year":"2021","unstructured":"Roux B, Berthou-Contreras J, Beuscart J-B, Charenton-Blavignac M, Doucet J, Fournier J-P, et al. REview of potentially inappropriate MEDIcation pr[e]scribing in Seniors (REMEDI[e]S): French implicit and explicit criteria. Eur J Clin Pharmacol. 2021;77:1713\u201324. https:\/\/doi.org\/10.1007\/s00228-021-03145-6.","journal-title":"Eur J Clin Pharmacol"},{"key":"7113_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","volume":"14","author":"D O\u2019Mahony","year":"2023","unstructured":"O\u2019Mahony D, Cherubini A, Guiteras AR, Denkinger M, Beuscart J-B, Onder G, et al. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med. 2023;14:625\u201332. https:\/\/doi.org\/10.1007\/s41999-023-00777-y.","journal-title":"Eur Geriatr Med"},{"issue":"67","key":"7113_CR10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"2019","author":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society","year":"2019","unstructured":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society. Updated AGS beers criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;2019(67):674\u201394. https:\/\/doi.org\/10.1111\/jgs.15767.","journal-title":"J Am Geriatr Soc"},{"key":"7113_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1053\/j.ackd.2010.06.004","volume":"17","author":"KE Cardone","year":"2010","unstructured":"Cardone KE, Bacchus S, Assimon MM, Pai AB, Manley HJ. Medication-related problems in CKD. Adv Chronic Kidney Dis. 2010;17:404\u201312. https:\/\/doi.org\/10.1053\/j.ackd.2010.06.004.","journal-title":"Adv Chronic Kidney Dis"},{"key":"7113_CR12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/ckj\/sfz046","volume":"12","author":"IM Schmidt","year":"2019","unstructured":"Schmidt IM, H\u00fcbner S, Nadal J, Titze S, Schmid M, B\u00e4rthlein B, et al. Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German chronic kidney disease study. Clin Kidney J. 2019;12:663\u201372. https:\/\/doi.org\/10.1093\/ckj\/sfz046.","journal-title":"Clin Kidney J"},{"key":"7113_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40620-022-01477-9","volume":"36","author":"C Roux","year":"2023","unstructured":"Roux C, Verollet K, Prouvot J, Prelipcean C, Pambrun E, Moranne O. Choosing the right chronic medication for hemodialysis\u00a0patients. A short ABC for the dialysis nephrologist. J Nephrol. 2023;36:521\u201336. https:\/\/doi.org\/10.1007\/s40620-022-01477-9.","journal-title":"J Nephrol"},{"key":"7113_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12882-024-03606-x","volume":"25","author":"B Zhang","year":"2024","unstructured":"Zhang B, Wang J, Liu N, Liu W, Xi R, Wang P. Association between polypharmacy and chronic kidney disease among community-dwelling older people: a longitudinal study in southern China. BMC Nephrol. 2024;25:169. https:\/\/doi.org\/10.1186\/s12882-024-03606-x.","journal-title":"BMC Nephrol"},{"key":"7113_CR15","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1093\/ndt\/gfab342","volume":"37","author":"E Schaeffner","year":"2022","unstructured":"Schaeffner E. Smoothing transition to dialysis to improve early outcomes after dialysis initiation among old and frail adults\u2014a narrative review. Nephrol Dial Transplant. 2022;37:2307\u201313. https:\/\/doi.org\/10.1093\/ndt\/gfab342.","journal-title":"Nephrol Dial Transplant"},{"key":"7113_CR16","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1681\/ASN.V114740","volume":"11","author":"P Arora","year":"2000","unstructured":"Arora P, Kausz AT, Obrador GT, Ruthazer R, Khan S, Jenuleson CS, et al. Hospital utilization among chronic dialysis patients. J Am Soc Nephrol. 2000;11:740. https:\/\/doi.org\/10.1681\/ASN.V114740.","journal-title":"J Am Soc Nephrol"},{"key":"7113_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40266-024-01166-1","volume":"42","author":"A Visaria","year":"2025","unstructured":"Visaria A, McDonald W, Mancini J, Ambrosy AP, Kwak MJ, Hashemi A, et al. Changes in medication complexity and post-hospitalization outcomes in older adults hospitalized for heart failure. Drugs Aging. 2025;42:69\u201380. https:\/\/doi.org\/10.1007\/s40266-024-01166-1.","journal-title":"Drugs Aging"},{"key":"7113_CR18","doi-asserted-by":"publisher","first-page":"204062232211083","DOI":"10.1177\/20406223221108397","volume":"13","author":"M Raffray","year":"2022","unstructured":"Raffray M, Vigneau C, Couchoud C, Laude L, Camp\u00e9on A, Schweyer F-X, et al. The dynamics of the general practitioner-nephrologist collaboration for the management of patients with chronic kidney disease before and after dialysis initiation: a mixed-methods study. Ther Adv Chronic Dis. 2022;13:20406223221108396. https:\/\/doi.org\/10.1177\/20406223221108397.","journal-title":"Ther Adv Chronic Dis"},{"key":"7113_CR19","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2215\/CJN.10611015","volume":"11","author":"TI Chang","year":"2016","unstructured":"Chang TI, Zheng Y, Montez-Rath ME, Winkelmayer WC. Antihypertensive medication use in older patients transitioning from chronic kidney disease to end-stage renal disease on dialysis. Clin J Am Soc Nephrol. 2016;11:1401\u201312. https:\/\/doi.org\/10.2215\/CJN.10611015.","journal-title":"Clin J Am Soc Nephrol"},{"key":"7113_CR20","doi-asserted-by":"publisher","first-page":"205435812091265","DOI":"10.1177\/2054358120912652","volume":"7","author":"JG Marin","year":"2020","unstructured":"Marin JG, Beresford L, Lo C, Pai A, Espino-Hernandez G, Beaulieu M. Prescription patterns in dialysis patients: differences between hemodialysis and peritoneal dialysis patients and opportunities for deprescription. Can J Kidney Health Dis. 2020;7:2054358120912652. https:\/\/doi.org\/10.1177\/2054358120912652.","journal-title":"Can J Kidney Health Dis"},{"key":"7113_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1365-2125.2005.02417.x","volume":"60","author":"S Hartikainen","year":"2005","unstructured":"Hartikainen S, M\u00e4ntyselk\u00e4 P, Louhivuori-Laako K, Enlund H, Sulkava R. Concomitant use of analgesics and psychotropics in home-dwelling elderly people \u2013 Kuopio 75 + study. Br J Clin Pharmacol. 2005;60:306\u201310. https:\/\/doi.org\/10.1111\/j.1365-2125.2005.02417.x.","journal-title":"Br J Clin Pharmacol"},{"key":"7113_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/ckj\/sfw013","volume":"9","author":"AS Artan","year":"2016","unstructured":"Artan AS, Kircelli F, Ok E, Yilmaz M, Asci G, Dogan C, et al. Dialyzing women and men: does it matter? An observational study. Clin Kidney J. 2016;9:486\u201393. https:\/\/doi.org\/10.1093\/ckj\/sfw013.","journal-title":"Clin Kidney J"},{"key":"7113_CR23","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3390\/life13051140","volume":"13","author":"I Kontogiorgos","year":"2023","unstructured":"Kontogiorgos I, Georgianos PI, Vaios V, Vareta G, Georgianou E, Karligkiotis A, et al. Gender-related differences in the levels of ambulatory BP and intensity of antihypertensive treatment in patients undergoing peritoneal dialysis. Life (Basel). 2023;13:1140. https:\/\/doi.org\/10.3390\/life13051140.","journal-title":"Life (Basel)"},{"key":"7113_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.nephro.2022.01.004","volume":"18","author":"A Caillet","year":"2022","unstructured":"Caillet A, Mazou\u00e9 F, Wurtz B, Larre X, Couchoud C, Lassalle M, et al. Which data in the French registry for advanced chronic kidney disease for public health and patient care? Nephrol Ther. 2022;18:228\u201336. https:\/\/doi.org\/10.1016\/j.nephro.2022.01.004.","journal-title":"Nephrol Ther"},{"key":"7113_CR25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/ndt\/gfi198","volume":"21","author":"C Couchoud","year":"2006","unstructured":"Couchoud C, Stengel B, Landais P, Aldigier J-C, de Cornelissen F, Dabot C, et al. The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France. Nephrol Dial Transplant. 2006;21:411\u20138. https:\/\/doi.org\/10.1093\/ndt\/gfi198.","journal-title":"Nephrol Dial Transplant"},{"key":"7113_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.respe.2010.04.005","volume":"58","author":"P Tuppin","year":"2010","unstructured":"Tuppin P, de Roquefeuil L, Weill A, Ricordeau P, Merli\u00e8re Y. French national health insurance information system and the permanent beneficiaries sample. Rev Epidemiol Sante Publique. 2010;58:286\u201390. https:\/\/doi.org\/10.1016\/j.respe.2010.04.005.","journal-title":"Rev Epidemiol Sante Publique"},{"key":"7113_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12882-020-1692-4","volume":"21","author":"M Raffray","year":"2020","unstructured":"Raffray M, Bayat S, Lassalle M, Couchoud C. Linking disease registries and nationwide healthcare administrative databases: the French renal epidemiology and information network (REIN) insight. BMC Nephrol. 2020;21:25. https:\/\/doi.org\/10.1186\/s12882-020-1692-4.","journal-title":"BMC Nephrol"},{"key":"7113_CR28","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/pds.1717","volume":"18","author":"P Noize","year":"2009","unstructured":"Noize P, Bazin F, Dufouil C, Lechevallier-Michel N, Ancelin M, Dartigues J, et al. Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) study. Pharmacoepidemiol Drug. 2009;18:310\u20139. https:\/\/doi.org\/10.1002\/pds.1717.","journal-title":"Pharmacoepidemiol Drug"},{"key":"7113_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s002280050329","volume":"53","author":"L Bjerrum","year":"1997","unstructured":"Bjerrum L, Rosholm JU, Hallas J, Kragstrup J. Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol. 1997;53:7\u201311. https:\/\/doi.org\/10.1007\/s002280050329.","journal-title":"Eur J Clin Pharmacol"},{"key":"7113_CR30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:230. https:\/\/doi.org\/10.1186\/s12877-017-0621-2.","journal-title":"BMC Geriatr"},{"key":"7113_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s40801-015-0036-3","volume":"2","author":"IC Kann","year":"2015","unstructured":"Kann IC, Lundqvist C, Lur\u00e5s H. Polypharmacy among the elderly in a list-patient system. Drugs Real World Outcomes. 2015;2:193. https:\/\/doi.org\/10.1007\/s40801-015-0036-3.","journal-title":"Drugs Real World Outcomes"},{"key":"7113_CR32","doi-asserted-by":"publisher","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD). Kidney International Supplements 2017. https:\/\/doi.org\/10.1016\/j.kisu.2017.04.001.","DOI":"10.1016\/j.kisu.2017.04.001"},{"key":"7113_CR33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2215\/CJN.05080418","volume":"14","author":"S Sibbel","year":"2019","unstructured":"Sibbel S, Walker AG, Colson C, Tentori F, Brunelli SM, Flythe J. Association of continuation of loop diuretics at hemodialysis initiation with clinical outcomes. Clin J Am Soc Nephrol. 2019;14:95\u2013102. https:\/\/doi.org\/10.2215\/CJN.05080418.","journal-title":"Clin J Am Soc Nephrol"},{"key":"7113_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2165\/00003088-198409010-00003","volume":"9","author":"CC Lee","year":"1984","unstructured":"Lee CC, Marbury TC. Drug therapy in patients undergoing haemodialysis clinical pharmacokinetic considerations. Clin Pharmacokinet. 1984;9:42\u201366. https:\/\/doi.org\/10.2165\/00003088-198409010-00003.","journal-title":"Clin Pharmacokinet"},{"key":"7113_CR35","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/pds.1344","volume":"16","author":"P Carrasco-Garrido","year":"2007","unstructured":"Carrasco-Garrido P, Jim\u00e9nez-Garc\u00eda R, Astasio-Arbiza P, Ortega-Molina P, de Miguel AG. Psychotropics use in the Spanish elderly: predictors and evolution between years 1993 and 2003. Pharmacoepidemiol Drug Saf. 2007;16:449\u201357. https:\/\/doi.org\/10.1002\/pds.1344.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"7113_CR36","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/gps.712","volume":"17","author":"T Linjakumpu","year":"2002","unstructured":"Linjakumpu T, Hartikainen S, Klaukka T, Koponen H, Kivel\u00e4 S-L, Isoaho R. Psychotropics among the home-dwelling elderly\u2014increasing trends. Int J Geriatr Psychiatry. 2002;17:874\u201383. https:\/\/doi.org\/10.1002\/gps.712.","journal-title":"Int J Geriatr Psychiatry"},{"key":"7113_CR37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2165\/00002512-200421030-00002","volume":"21","author":"V Lorenzo Sellares","year":"2004","unstructured":"Lorenzo Sellares V, Torres Ram\u00edrez A. Management of hyperphosphataemia in dialysis patients: role of phosphate binders in the elderly. Drugs Aging. 2004;21:153\u201365. https:\/\/doi.org\/10.2165\/00002512-200421030-00002.","journal-title":"Drugs Aging"},{"key":"7113_CR38","unstructured":"HAS. M\u00e9dicaments inhibiteurs de la pompe \u00e0 proton chez l\u2019adulte\u202f: r\u00e9\u00e9valuation. 2009. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2009-04\/argumentaire_ipp_2009-04-27_14-15-18_458.pdf."},{"key":"7113_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.lfs.2018.12.058","volume":"218","author":"J Liu","year":"2019","unstructured":"Liu J, Li X, Fan L, Yang J, Wang J, Sun J, et al. Proton pump inhibitors therapy and risk of bone diseases: an update meta-analysis. Life Sci. 2019;218:213\u201323. https:\/\/doi.org\/10.1016\/j.lfs.2018.12.058.","journal-title":"Life Sci"},{"key":"7113_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00198-017-4262-2","volume":"29","author":"S-M Lin","year":"2018","unstructured":"Lin S-M, Yang S-H, Liang C-C, Huang H-K. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study. Osteoporos Int. 2018;29:153\u201362. https:\/\/doi.org\/10.1007\/s00198-017-4262-2.","journal-title":"Osteoporos Int"},{"key":"7113_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejim.2019.11.002","volume":"72","author":"I Kosedo","year":"2020","unstructured":"Kosedo I, Tokushige A, Takumi T, Yoshikawa A, Teraguchi K, Takenouchi K, et al. Use of proton pump inhibitors is associated with an increase in adverse cardiovascular events in patients with hemodialysis: insight from the kids registry. Eur J Intern Med. 2020;72:79\u201387. https:\/\/doi.org\/10.1016\/j.ejim.2019.11.002.","journal-title":"Eur J Intern Med"},{"key":"7113_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.23876\/j.krcp.18.0060","volume":"38","author":"M Kim","year":"2019","unstructured":"Kim M, Kim CS, Bae EH, Ma SK, Kim SW. Risk factors for peptic ulcer disease in patients with end-stage renal disease receiving dialysis. Kidney Res Clin Pract. 2019;38:81. https:\/\/doi.org\/10.23876\/j.krcp.18.0060.","journal-title":"Kidney Res Clin Pract"},{"key":"7113_CR43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ejim.2010.11.009","volume":"22","author":"L Pasina","year":"2011","unstructured":"Pasina L, Nobili A, Tettamanti M, Salerno F, Corrao S, Marengoni A, et al. Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly. Eur J Intern Med. 2011;22:205\u201310. https:\/\/doi.org\/10.1016\/j.ejim.2010.11.009.","journal-title":"Eur J Intern Med"},{"key":"7113_CR44","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/ndt\/18.3.570","volume":"18","author":"H Strid","year":"2003","unstructured":"Strid H, Simr\u00e9n M, Bj\u00f6rnsson ES. Overuse of acid suppressant drugs in patients with chronic renal failure. Nephrol Dial Transplant. 2003;18:570\u20135. https:\/\/doi.org\/10.1093\/ndt\/18.3.570.","journal-title":"Nephrol Dial Transplant"},{"key":"7113_CR45","doi-asserted-by":"publisher","first-page":"ii91","DOI":"10.1093\/ndt\/gfw357","volume":"32","author":"K Kalantar-Zadeh","year":"2017","unstructured":"Kalantar-Zadeh K, Kovesdy CP, Streja E, Rhee CM, Soohoo M, Chen JLT, et al. Transition of care from pre-dialysis prelude to renal replacement therapy: the blueprints of emerging research in advanced chronic kidney disease. Nephrol Dial Transplant. 2017;32:ii91-8. https:\/\/doi.org\/10.1093\/ndt\/gfw357.","journal-title":"Nephrol Dial Transplant"},{"key":"7113_CR46","doi-asserted-by":"publisher","first-page":"sfae281","DOI":"10.1093\/ckj\/sfae281","volume":"17","author":"F Guerville","year":"2024","unstructured":"Guerville F, P\u00e9pin M, Garnier-Crussard A, Beuscart J-B, Citarda S, Hocine A, et al. How to make a shared decision with older persons for end-stage kidney disease treatment: the added value of geronto-nephrology. Clin Kidney J. 2024;17:sfae281. https:\/\/doi.org\/10.1093\/ckj\/sfae281.","journal-title":"Clin Kidney J"},{"key":"7113_CR47","doi-asserted-by":"publisher","first-page":"205435812096867","DOI":"10.1177\/2054358120968674","volume":"7","author":"MJ Lefebvre","year":"2020","unstructured":"Lefebvre MJ, Ng PCK, Desjarlais A, McCann D, Waldvogel B, Tonelli M, et al. Development and validation of nine deprescribing algorithms for patients on hemodialysis to decrease polypharmacy. Can J Kidney Health Dis. 2020;7:2054358120968674. https:\/\/doi.org\/10.1177\/2054358120968674.","journal-title":"Can J Kidney Health Dis"},{"key":"7113_CR48","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1093\/ajhp\/zxac190","volume":"79","author":"S Gerardi","year":"2022","unstructured":"Gerardi S, Sperlea D, Levy SO-L, Bondurant-David K, Dang S, David P-M, et al. Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis. Am J Health Syst Pharm. 2022;79:S128-35. https:\/\/doi.org\/10.1093\/ajhp\/zxac190.","journal-title":"Am J Health Syst Pharm"},{"key":"7113_CR49","doi-asserted-by":"publisher","first-page":"100810","DOI":"10.1016\/j.xkme.2024.100810","volume":"6","author":"\u00c9 Bortolussi-Courval","year":"2024","unstructured":"Bortolussi-Courval \u00c9, Podymow T, Battistella M, Trinh E, Mavrakanas TA, McCarthy L, et al. Medication deprescribing in patients receiving hemodialysis: a prospective controlled quality improvement study. Kidney Med. 2024;6:100810. https:\/\/doi.org\/10.1016\/j.xkme.2024.100810.","journal-title":"Kidney Med"},{"key":"7113_CR50","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1093\/ndt\/gft296","volume":"28","author":"W van Biesen","year":"2013","unstructured":"van Biesen W, Claes K, Covic A, Fan S, Lichodziejewska-Niemierko M, Schoder V, et al. A multicentric, international matched pair analysis of body composition in peritoneal dialysis versus haemodialysis patients. Nephrol Dial Transplant. 2013;28:2620\u20138. https:\/\/doi.org\/10.1093\/ndt\/gft296.","journal-title":"Nephrol Dial Transplant"},{"key":"7113_CR51","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.18203\/2319-2003.ijbcp20151338","volume":"4","author":"Z Parmar","year":"2015","unstructured":"Parmar Z, Malhotra SD, Patel VJ. Prevalence and pattern of self-medication in elderly individuals. Intern J Basic Clin Pharmacol. 2015;4:1095\u20139. https:\/\/doi.org\/10.18203\/2319-2003.ijbcp20151338.","journal-title":"Intern J Basic Clin Pharmacol"},{"key":"7113_CR52","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.3390\/ijerph18115530","volume":"18","author":"E S\u00e1nchez-S\u00e1nchez","year":"2021","unstructured":"S\u00e1nchez-S\u00e1nchez E, Fern\u00e1ndez-Cerezo FL, D\u00edaz-Jimenez J, Rosety-Rodriguez M, D\u00edaz AJ, Ordonez FJ, et al. Consumption of over-the-counter drugs: prevalence and type of drugs. Int J Environ Res Public Health. 2021;18:5530. https:\/\/doi.org\/10.3390\/ijerph18115530.","journal-title":"Int J Environ Res Public Health"},{"key":"7113_CR53","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1001\/jama.2008.892","volume":"300","author":"DM Qato","year":"2008","unstructured":"Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300:2867. https:\/\/doi.org\/10.1001\/jama.2008.892.","journal-title":"JAMA"},{"key":"7113_CR54","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1053\/j.ajkd.2006.11.023","volume":"49","author":"M-C Lalibert\u00e9","year":"2007","unstructured":"Lalibert\u00e9 M-C, Normandeau M, Lord A, Lamarre D, Cantin I, Berbiche D, et al. Use of over-the-counter medications and natural products in patients with moderate and severe chronic renal insufficiency. Am J Kidney Dis. 2007;49:245\u201356. https:\/\/doi.org\/10.1053\/j.ajkd.2006.11.023.","journal-title":"Am J Kidney Dis"},{"key":"7113_CR55","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/pds.4233","volume":"26","author":"J Bezin","year":"2017","unstructured":"Bezin J, Duong M, Lassalle R, Droz C, Pariente A, Blin P, et al. The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2017;26:954\u201362. https:\/\/doi.org\/10.1002\/pds.4233.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-026-07113-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07113-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07113-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:37:51Z","timestamp":1776663471000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12877-026-07113-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7113"],"URL":"https:\/\/doi.org\/10.1186\/s12877-026-07113-6","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The REIN registry was approved by the relevant French committees, the Comit\u00e9 consultatif sur le traitement de l\u2019information en mati\u00e8re de recherch\u00e9 (CCTIRS N\u00b003\u2013149) and the Commission nationale de l\u2019informatique et des libert\u00e9s (CNIL N\u00b0 903188). For population-based registries requiring exhaustiveness, French regulations require that patients be informed by the clinic that they can choose not to participate (opt-out). Patients\u2019 information have been anonymized and de-identified before the extraction for analysis. Access to the databases used in the present study was obtained from the REIN scientific committee and the CCTIRS (N\u00b015\u20131046) and CNIL (N\u00b0 916072). No consent to participate was required due to the retrospective nature of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"551"}}